中文速读
本研究使用Entranster-R4000转染试剂将miR-199a-5p mimic或inhibitor转染至MRL/lpr小鼠脾脏CD4+ T细胞,研究miR-199a-5p对T细胞衰老的影响,发现其通过Sirt1/p53通路调控衰老,为系统性红斑狼疮治疗提供新靶点。
小鼠脾miRNACD4+ T
Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis
Affiliations
- 1 Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008 China.
- 2 The State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center, Model Animal Research Center of Nanjing University, Nanjing, 210061 China.
- PMID: 33391511
- PMCID: PMC7738872
- DOI: 10.7150/thno.48080
Abstract
Rationale: Although human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) transplantation has been proved to be an effective therapeutic approach to treat systemic lupus erythematosus (SLE), the detailed underlying mechanisms are not fully understood. Transferring miRNAs is one mean by which MSCs communicate with surrounding cells. Sirt1 is a NAD-dependent deacetylase that protects against cell senescence by deacetylating p53. Here we aimed to explore whether hUC-MSCs affected senescence of splenic CD4+ T cells through regulating Sirt1/p53 via miRNA in the MRL/lpr lupus mouse model. Methods: The effects of hUC-MSCs on lupus syndrome and senescence pathways in MRL/lpr mice in vivo and in vitro were determined. The functional roles of miR-199a-5p in splenic CD4+ T cell senescence were studied by miRNA mimic or inhibitor in vitro. MRL/lpr mice were injected with miR-199a-5p agomir to evaluate the effects of miR-199a-5p on splenic CD4+ T cell senescence and disease in vivo.Results: We showed that hUC-MSCs transplantation ameliorated lupus symptoms and increased senescence of splenic CD4+ T cells through Sirt1/p53 signaling via miR-199a-5p in MRL/lpr mice. Moreover, systemic delivery of miR-199a-5p in MRL/lpr mice increased splenic CD4+ T-cell senescence, mimicking the therapeutic effects of transplanted hUC-MSCs. Conclusions: We have identified miR-199a-5p as one of the mechanisms employed by hUC-MSCs to alleviate lupus disease associated pathologies in MRL/lpr mice, which is attributable for promoting splenic CD4+ T cell senescence through Sirt1/p53 pathway.
Keywords: Lupus; Mesenchymal stem cells; Senescence; Sirt1/p53; miR-199a-5p.
小核酸转染试剂Entranster™-R4000 已有 222 篇已发表文献
同类研究
- Biomolecules. 2026 May 19;16(5):741.doi: 10.3390/biom16050741. Up-Regulation of the TRPM8 Channel Attenuates TRPC1-Media…
- FASEB J. 2026 May 15;40(9):e71855.doi: 10.1096/fj.202503895RR. High-Fat Diet Induces Inflammatory Injury in Mice Sertoli…
- Biochem Pharmacol. 2026 Jan 20:246:117723.doi: 10.1016/j.bcp.2026.117723. Small nucleolar RNA host gene 3 regulates seps…
- Autoimmunity. 2025 Dec;58(1):2576881.doi: 10.1080/08916934.2025.2576881. High glucose promotes O-GlcNAcylation of ACSL4…
- BMC Cancer. 2025 Oct 10;25(1):1553.doi: 10.1186/s12885-025-14854-x. PCBP1-AS1 facilitates liver metastasis in pancreatic…